Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo

NCT07683026 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

255

Enrollment

NIH

Sponsor class

Conditions

Type 1 Diabetes (T1D)

Interventions

DRUG: Golimumab
DRUG: Placebo (matching golimumab)

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)